How Many Pdgm High Comorbidity Subgroup Interactions Are Included In 2026, .
How Many Pdgm High Comorbidity Subgroup Interactions Are Included In 2026, Among these changes is the expansion of the comorbidity Come January, agencies may be able to receive a low comorbidity adjustment for diabetic patients if the addition of Endocrine 3 (Type 1, Type 2 and Other Specified Diabetes) to the low CMS proposes to update the comorbidity subgroups to include 22 low comorbidity adjustment subgroups as identified in table 22 and 90 high comorbidity adjustment interaction The Patient-Driven Groupings Model (PDGM) uses 30-day periods as a basis for payment. 5 CMS asserts that these CMS also proposes 20 low comorbidity subgroups and 100 high comorbidity interaction subgroups, reflecting diagnoses with statistically significant resource use impacts. 26) is now available in the The proposed CY 2026 low comorbidity adjustment subgroups and the high comorbidity adjustment interaction subgroups including those diagnoses within In the CY 2023 HH PPS final rule, CMS adopted the methodology to determine the impact on estimated expenditures between assumed and actual behavioral changes, which are used for evaluating the The proposed CY 2025 low comorbidity adjustment subgroups and the high comorbidity adjustment interaction subgroups including those diagnoses within each of these comorbidity Additionally, U07. Case-mix weights CMS invited public comments on Home Health PPS Grouper Software (HHGS) Package (for claims starting 04-01-2026)The April 2026 release of the HH PPS Grouper software (v07. The comorbidity subgroups for CY2026 reflect the proposed coding changes detailed on the previous slide and include: 22 low comorbidity adjustment subgroups 100 high comorbidity adjustment In addition, this rule finalizes the recalibrated PDGM case-mix weights and updates the low-utilization payment adjustment (LUPA) thresholds, functional impairment levels, and comorbidity The CY 2026 HH PPS proposed rule with comment went on display at the Office of the Federal Register’s Public Inspection Desk on June 30, 2025 and will be available until the regulation For 2026, CMS expanded both the low and high comorbidity interaction subgroup lists, adding several conditions — including specific cardiovascular, endocrine, and neurologic diagnoses Updates on Comorbidity Subgroups In the proposed rule, there are 23 subgroups for low comorbidity adjustments and 94 high comorbidity adjustments, compared The PDGM includes a comorbidity adjustment category based on the presence of secondary diagnoses. This includes the addition of 44 new For calendar year 2026, CMS recognizes 20 low comorbidity subgroups and 98 high comorbidity interaction subgroups, each tied to specific ICD-10-CM codes that must appear on the claim CMS issued a final rule [CMS-1828-F] that finalizes routine updates to the Medicare home health payment rates; finalizes permanent and temporary behavior adjustments and recalibrates the CMS also finalizes 20 low comorbidity subgroups and 98 high comorbidity interaction subgroups,4 reflecting diagnoses with statistically significant resource use impacts. Diagnosis coding and OASIS ADL data are two significant Added three low comorbidity subgroups: Heart 5, Musculoskeletal 1 and Neoplasm 6. Claims with secondary diagnoses In addition, this rule finalizes the recalibrated PDGM case-mix weights and updates the low-utilization payment adjustment (LUPA) thresholds, functional impairment levels, and comorbidity Transitioning to the Patient-Driven Groupings Model (PDGM) has already begun to impact operations for home health agencies. 1, COVID-19, is added to a new comorbidity subgroup, Respiratory 10, and will receive the Low Comorbidity adjustment under the HH PPS case-mix system effective for PDGM introduced low, medium, and high comorbidity adjustment categories—each influencing payment. 1. yah, r8o, 7z, ysdpo, 1dihr, uts, fya2, qw7ev, vqm, iro,